Chronic obstructive pulmonary disease (COPD) is a global health problem and since 2001 the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy document for the diagnosis and management of COPD. This executive summary presents the main contents of the second 5-year revision of the GOLD document that has implemented some of the vast knowledge about COPD accumulated over the last years. Today, GOLD recommends that spirometry is required for the clinical diagnosis of COPD in order to avoid misdiagnosis and to ensure proper evaluation of severity of airflow limitation. The document highlights that the assessment of the COPD patient should always include assessment of 1) symptoms, 2) severity of airflow limitation, 3) history of exacerbations, and 4) comorbidities. The first three points can be used to evaluate level of symptoms and risk of future exacerbations and this is done in a way that split COPD patients into 4 categories - A, B, C and D. Non-pharmacologic and pharmacologic management of COPD match this assessment in an evidence-based attempt to relieve symptoms and reduce risk of exacerbations. Identification and treatment of comorbidities must have high priority and a separate chapter in the document addresses management of comorbidities as well as COPD in the presence of comorbidities. The revised document also contains a new chapter on exacerbations of COPD. The GOLD initiative will continue to bring COPD to the attention of all relevant shareholders a

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary / Vestbo, J; Hurd, Ss; Agusti, Ag; Jones, Pw; Vogelmeier, C; Anzueto, A; Barnes, Pj; Fabbri, Leonardo; Martinez, Fj; Nishimura, M; Stockley, Ra; Sin, Dd; Rodriguez Roisin, R.. - In: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. - ISSN 1073-449X. - STAMPA. - 187:(2013), pp. 347-365. [10.1164/rccm.201204-0596PP]

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

FABBRI, Leonardo;
2013

Abstract

Chronic obstructive pulmonary disease (COPD) is a global health problem and since 2001 the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy document for the diagnosis and management of COPD. This executive summary presents the main contents of the second 5-year revision of the GOLD document that has implemented some of the vast knowledge about COPD accumulated over the last years. Today, GOLD recommends that spirometry is required for the clinical diagnosis of COPD in order to avoid misdiagnosis and to ensure proper evaluation of severity of airflow limitation. The document highlights that the assessment of the COPD patient should always include assessment of 1) symptoms, 2) severity of airflow limitation, 3) history of exacerbations, and 4) comorbidities. The first three points can be used to evaluate level of symptoms and risk of future exacerbations and this is done in a way that split COPD patients into 4 categories - A, B, C and D. Non-pharmacologic and pharmacologic management of COPD match this assessment in an evidence-based attempt to relieve symptoms and reduce risk of exacerbations. Identification and treatment of comorbidities must have high priority and a separate chapter in the document addresses management of comorbidities as well as COPD in the presence of comorbidities. The revised document also contains a new chapter on exacerbations of COPD. The GOLD initiative will continue to bring COPD to the attention of all relevant shareholders a
2013
187
347
365
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary / Vestbo, J; Hurd, Ss; Agusti, Ag; Jones, Pw; Vogelmeier, C; Anzueto, A; Barnes, Pj; Fabbri, Leonardo; Martinez, Fj; Nishimura, M; Stockley, Ra; Sin, Dd; Rodriguez Roisin, R.. - In: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. - ISSN 1073-449X. - STAMPA. - 187:(2013), pp. 347-365. [10.1164/rccm.201204-0596PP]
Vestbo, J; Hurd, Ss; Agusti, Ag; Jones, Pw; Vogelmeier, C; Anzueto, A; Barnes, Pj; Fabbri, Leonardo; Martinez, Fj; Nishimura, M; Stockley, Ra; Sin, Dd; Rodriguez Roisin, R.
File in questo prodotto:
File Dimensione Formato  
rccm%2E201204-0596pp.pdf

Accesso riservato

Descrizione: articolo principale
Tipologia: Versione pubblicata dall'editore
Dimensione 242.34 kB
Formato Adobe PDF
242.34 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/904090
Citazioni
  • ???jsp.display-item.citation.pmc??? 1950
  • Scopus 4049
  • ???jsp.display-item.citation.isi??? 2938
social impact